Diverse TRPV1 responses to cannabinoids

被引:43
|
作者
Starkus, J. [1 ]
Jansen, C. [1 ]
Shimoda, L. M. N. [1 ]
Stokes, A. J. [2 ]
Small-Howard, A. L. [3 ]
Turner, H. [1 ]
机构
[1] Chaminade Univ, Lab Immunol & Signal Transduct, Honolulu, HI 96816 USA
[2] John A Burns Sch Med, Lab Expt Med, Honolulu, HI USA
[3] GBSciences Inc, Las Vegas, NV USA
基金
美国国家卫生研究院;
关键词
TRP channels; cannabinoids; pain; calcium; oxidation; POTENTIAL VANILLOID 1; TOPICAL CAPSAICIN; CA2+-DEPENDENT DESENSITIZATION; COMPETITIVE ANTAGONIST; MEDICAL MARIJUANA; CHRONIC PAIN; CHANNELS; CANNABIDIOL; CAPSAZEPINE; ACTIVATION;
D O I
10.1080/19336950.2019.1619436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cannabinoid compounds are potential analgesics. Users of medicinal Cannabis report efficacy for pain control, clinical studies show that cannabis can be effective and opioid sparing in chronic pain, and some constituent cannabinoids have been shown to target nociceptive ion channels. Here, we explore and compare a suite of cannabinoids for their impact upon the physiology of TRPV1. The cannabinoids tested evoke differential responses in terms of kinetics of activation and inactivation. Cannabinoid activation of TRPV1 displays significant dependence on internal and external calcium levels. Cannabinoid activation of TRPV1 does not appear to induce the highly permeant, pore-dilated channel state seen with Capsaicin, even at high current amplitudes. Finally, we analyzed cannabinoid responses at nociceptive channels other than TRPV1 (TRPV2, TRPM8, and TRPA1), and report that cannabinoids differentially activate these channels. On the basis of response activation and kinetics, state-selectivity and receptor selectivity, it may be possible to rationally design approaches to pain using single or multiple cannabinoids.
引用
收藏
页码:172 / 191
页数:20
相关论文
共 50 条
  • [21] Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels
    Fatahi, Zahra
    Reisi, Zahra
    Rainer, Gregor
    Haghparast, Abbas
    Khani, Abbas
    NEUROPHARMACOLOGY, 2018, 133 : 75 - 84
  • [22] Cytoskeletal interactions with TRPV1
    Hucho, F
    Goswami, C
    Bogen, O
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 222 - 222
  • [23] DMSO activates TRPV1
    Paule, C.
    Davis, J. B.
    Nagy, I.
    NEUROPEPTIDES, 2008, 42 (04) : 482 - 482
  • [24] Inflammatory signals to TRPV1
    Kim, BM
    Oh, U
    HYPERALGESIA: MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS, 2004, 30 : 27 - 36
  • [25] A "Cute" Desensitization of TRPV1
    Touska, Filip
    Marsakova, Lenka
    Teisinger, Jan
    Vlachova, Viktorie
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (01) : 122 - 129
  • [26] TRPV1 in migraine pathophysiology
    Meents, Jannis E.
    Neeb, Lars
    Reuter, Uwe
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (04) : 153 - 159
  • [27] Biological Functions of TRPV1
    Liu Xia-Yang
    Li Zhuang
    Zhou Xin-Yue
    Guo Xiao-Hong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (03) : 437 - 447
  • [28] TRPV1 and Synaptic Transmission
    Matta, Jose A.
    Ahern, Gerard P.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (01) : 95 - 101
  • [29] The TRPV1 receptor and nociception
    Immke, David C.
    Gavva, Narender R.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2006, 17 (05) : 582 - 591
  • [30] Phosphoinositide Regulation of TRPV1
    Lukacs, Viktor
    Thyagarajan, Baskaran
    Rohacs, Tibor
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 342A - 342A